- Home
- TENX vs LRE Comparison
TENX vs LRE Comparison
Compare TENX & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- LRE
- Stock Information
- Founded
- TENX 1967
- LRE 2001
- Country
- TENX United States
- LRE Japan
- Employees
- TENX N/A
- LRE N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- TENX Health Care
- LRE
- Exchange
- TENX Nasdaq
- LRE Nasdaq
- Market Cap
- TENX 21.7M
- LRE 18.3M
- IPO Year
- TENX N/A
- LRE 2023
- Fundamental
- Price
- TENX $6.30
- LRE $1.25
- Analyst Decision
- TENX Strong Buy
- LRE
- Analyst Count
- TENX 3
- LRE 0
- Target Price
- TENX $16.00
- LRE N/A
- AVG Volume (30 Days)
- TENX 20.7K
- LRE 2.6K
- Earning Date
- TENX 05-13-2025
- LRE 01-01-0001
- Dividend Yield
- TENX N/A
- LRE N/A
- EPS Growth
- TENX N/A
- LRE N/A
- EPS
- TENX N/A
- LRE 0.29
- Revenue
- TENX N/A
- LRE $117,804,154.00
- Revenue This Year
- TENX N/A
- LRE N/A
- Revenue Next Year
- TENX N/A
- LRE N/A
- P/E Ratio
- TENX N/A
- LRE $4.20
- Revenue Growth
- TENX N/A
- LRE 8.82
- 52 Week Low
- TENX $2.77
- LRE $1.10
- 52 Week High
- TENX $7.89
- LRE $13.76
- Technical
- Relative Strength Index (RSI)
- TENX 49.26
- LRE 50.02
- Support Level
- TENX $6.00
- LRE $1.19
- Resistance Level
- TENX $6.76
- LRE $1.26
- Average True Range (ATR)
- TENX 0.40
- LRE 0.04
- MACD
- TENX 0.02
- LRE 0.03
- Stochastic Oscillator
- TENX 39.47
- LRE 82.37
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.